Aim: To develop and psychometrically test the validity of the Female Self-Advocacy in Cancer Survivorship Scale.
| INTRODUCTION
Self-advocacy is defined as an individual's ability to get her needs and priorities met in the face of a challenge (Hagan & Donovan, 2013a) . Such needs may include uncontrolled symptoms, making decisions about treatment, managing family and professional responsibilities, or any other physical, social, emotional or situation in which a survivor's health and quality of life are challenged. A cancer survivor (defined as any individual from the time of a cancer diagnosis through the end of life) self-advocates in three separate but complementary skills of making informed, personally meaningful decisions, communicating preferences and needs to healthcare providers, and balancing the receipt of support with the giving of care to others (Hagan & Donovan, 2013a) . Cancer survivors who self-advocate may excel in one, two or all three of these domains but can apply any of these skills to ensuring that they are receiving the care they need to receive quality, patientcentred cancer care. Self-advocacy is similar to concepts of selfmanagement and patient engagement in its emphasis on autonomy and self-determination, but distinct in its focus on overcoming challenges within an illness. While self-advocacy is a well-established concept within the HIV/AIDS and disability patient populations (Brashers, Haas, & Neidig, 1999; Test, Fowler, Wood, Brewer, & Eddy, 2005) , it has not received the same amount of conceptual clarity within the cancer population (Walsh-Burke & Marcusen, 1999) despite being equally needed and supported by advocacy organizations (Clark & Stovall, 1995; Shapiro et al., 2009 ). This lack of conceptual clarity prevents providers, patients and researchers from being able to provide targeted, consistent support to cancer survivors who need to advocate for their needs and priorities. Therefore, we aimed to develop and evaluate the concept of self-advocacy within the context of this nascent but superficial theoretical background.
| Background
Existing theories and measurements of self-advocacy from other patient populations inadequately represent the unique needs of individuals with cancer. For example, researchers administered the Patient Self-Advocacy Scale-a measurement tool developed among individuals with HIV/AIDS-to cancer survivors and found that the scale's psychometric properties largely diminished, especially among female participants (Hermansen-Kobulnicky, 2008) . Part of the discontinuity between how the two patient populations responded to the scale may relate to the distinct challenges females face while managing the psychological and physical side-effects of cancer and its treatment.
Gender differences in symptom prevalence and severity (Keogh, 2014) , preferences for care delivery (Wessels et al., 2010) and communication with healthcare providers (Cooper-Patrick et al., 1999; Elderkin-Thompson & Waitzkin, 1999) place female patients with cancer at risk for poor health outcomes, such as increased symptom burden and healthcare utilization (Bertakis & Azari, 2012 ). For example, female patients with cancer are known to experience pain, fatigue and depression at higher levels than male patients with cancer (Miaskowski, 2004 ). Yet, when communicating and negotiating with healthcare providers, women tend to prioritize agreement (maintaining the patient-provider relationship) and avoid discordance (questioning or demanding something from the provider), (Sheppard, Why is this research or review needed?
• Currently, no scale for patient self-advocacy exists for cancer survivors (i.e., anyone with a history of a cancer diagnosis).
• Based on our previous qualitative research findings, a review of the literature, and a content validity study of our preliminary scale, we created a theoretically based scale of self-advocacy for female cancer survivors in addition to a measurement model relating self-advocacy to its predictors, moderators and outcomes.
• Women with cancer self-advocate in specific ways both due to gender differences in communication, negotiation, and specific unmet needs they have related to their care.
What are the key findings?
• Our evaluation of five a priori hypotheses about how the Female Self-Advocacy in Cancer Survivorship Scale should function if it captures the construct of patient self-advocacy showed that the scale demonstrated sufficient construct validity and reliability evidence to be considered psychometrically strong.
• The scale's three dimensions of Being an Informed Deci- How should the findings be used to influence policy/practice/research/education?
• This scale can be used to assess a woman's ability to stand up for herself in the face of a challenge.
• Our measurement model of self-advocacy in which selfadvocacy is positively related to improved symptom burden and appropriate use of healthcare services indicates that women who struggle to self-advocate may require additional assistance in managing their symptoms and navigating the healthcare system.
• While we will conduct additional analyses and testing to continue to refine the scale, the construct of self-advocacy among female cancer survivors is robust enough to begin developing theoretically consistent programs to address the needs of women who struggle to self-advocate.
Adams, Lamdan, & Taylor, 2011) potentially leading to worse outcomes such as poor symptom control and over-utilization of services.
Women with cancer are also more likely than men to prefer a passive role in decision-making, which can impact the quality of care they receive (Brashers, Haas, Klingle, & Neidig, 2000; Sharma, Prigerson, Penedo, & Maciejewski, 2015) . More broadly, the social cultural context within which female cancer survivors are situated has an impact on the ways in which they communicate, negotiate and seek out support from the healthcare system, her caregivers and her support system (Surbone & Kagawa-Singer, 2013) . Without a valid, reliable measure of self-advocacy specific to the needs of female cancer survivors, clinicians and researchers are unable to assess self-advocacy among cancer survivors, and intervene for patients at risk for poor outcomes associated with low self-advocacy.
The purpose of the current study is to evaluate the construct validity of the Female Self-Advocacy in Cancer Survivorship (FSACS) Scale to test the accuracy by which it can be used to make inferences about women's abilities to self-advocate.
| Methodology
We completed a multiphase instrument development process to create a measure of self-advocacy specific to female cancer survivors.
Prior to the current study, we conducted a literature review (Hagan & Donovan, 2013a) and focus group study (Hagan & Donovan, 2013b ) that defined the concept of self-advocacy and lived experiences of cancer survivors overcoming challenges related to their health and care. Using the initial dimensions of self-advocacy uncovered in these two studies, we developed a preliminary scale to define the behaviours of self-advocacy among female cancer survivors. Next, we conducted a content validity study with a panel of content experts to further refine the scale (Hagan, Cohen, Stone, & Donovan, 2016) . Finally, we evaluated the scale's initial reliability as a necessary precursor to construct validity (Hagan et al., 2016) . 
| Participants
We used a cross-sectional mixed-mode survey study design. The inclusion criteria were: (1) female; (2) invasive cancer diagnosis ≥18 years old; and (3) ability to read and write in English. We recruited using a mixture of random and convenience sampling from the Pennsylvania Tumour Registry, a patient registry at the University of Pittsburgh, and seven national and local advocacy organizations. We aimed to recruit a representative sample of female cancer survivors including multiple cancer types and times since diagnosis. Pennsylvania Tumour Registry is a state-wide data system that collects information on all news cancer diagnoses in the state including roughly 76,000 new cases per year. We randomly selected members of the registry from a list of women diagnosed with any type of invasive cancer for 15 selected years between 1985 -2013. We recruited a convenience sample by asking leaders of the patient registry and advocacy organizations to notify their members about the study through email, newsletters and/or in-person meetings. Interested women contacted the principal investigator who screened potential participants and mailed online or paper-based questionnaires to all eligible participants based on their preference. Tinsley and Tinsley (1987) and Comrey and Lee (2013) recommendations for factor analyses justify a sample of at least 300 participants.
| Measures
The FSACS Scale measures the ability of female cancer survivors to get their needs, priorities and desires met in the face of a challenge.
Based on a previous content analysis and qualitative exploration of self-advocacy, we developed an initial scale that was then tested among 40 women for initial reliability and face validity. A team of psychometric and content experts met to refine the scale and delete poor-performing items based on face validity results (e.g., feedback regarding items' relevancy, clarity and importance) and psychometric performance (e.g., internal consistency, test-retest reliability; Hagan et al., 2016) . From those findings, we derived a 57-item, 6-point Likert-type self-advocacy scale consisting of three dimensions: (1) "Application of Information" captures a woman's ability to find trustworthy information and apply it to herself; (2) "Connected Strength" refers to a woman's ability to balance her needs with the needs of others and gain strength through her relationships and; (3) "Leading my Health Care" exemplifies how a woman can build productive, respectful relationships with her healthcare team. Higher scores on the FSACS Scale indicate higher self-advocacy skills.
| Validity and reliability
We chose valid, reliable measures to capture the hypothesized predictors, outcomes and related concepts in the literature. Table 1 describes each construct along with its associated measure, Cron- 
| Data collection
Between July 2014 -March 2015, participants completed a set of eight valid, reliable questionnaires, the new FSACS Scale and one investigator-developed health history questionnaire. Dillman's (2002) Tailored Design Method of administering paper and online surveys guided the design and delivery of both mailed and online questionnaires. This evidence-based process for designing and delivering surveys aims to reduce survey error and improve data quality by leveraging principles of social exchange and leverage-saliency theories that emphasize building trust, increasing perceived rewards and limiting perceived costs of survey participation. We included refusal forms in the initial mailing to members of the Pennsylvania Tumour Registry to understand reasons for non-participation.
We mailed participants paper questionnaires with a preaddressed, pre-stamped return envelope. We emailed online questionnaires through Qualtrics, a secure web-based data management system. If participants did not return questionnaires, we sent them 
| Ethical considerations
We proactively addressed potential risks associated with this study including breach of confidentiality and privacy by using robust data security available through the HIPAA approved Qualtrics data management system and data management procedures among our research team members including the use of de-identified data and researcher trainings. The study was approved by our university's Institutional Review Board.
| Data analysis
We developed five a priori hypotheses to evaluate the FSACS Scale's performance and build evidence for construct validity based on the scale's factor structure; known differences between survivors (e.g., subgroups of survivors with various educational backgrounds and times since diagnosis who we anticipated would have dissimilar self-advocacy skills based on our previous work; Hagan & Donovan, 2013a,b; Hagan et al., 2016) ; and the relationship with self-advocacy and its theoretical predictors, outcomes, related concepts. Figure 1 illustrates our self-advocacy measurement model and how the hypotheses (described below) relate self-advocacy to its predictors, outcomes and related concepts. For ease of readability, we provide more details for each of the five hypotheses immediately prior to reporting the results. We determined the level of evidence for construct validity based on whether or not we rejected these hypotheses. Data analyses were conducted using SPSS Version 22.
| RESULTS
A total of N = 317 adult female cancer survivors completed study questionnaires. Among the sample, participants had an average age of 58.4 (median = 59; observed range = 21-95). Most participants were White (N = 281, 89.5%), married (N = 194, 61.8%), earned at least a bachelor's degree (N = 167, 53.3%), and had a median household income of at least $50,000 (N = 164, 54.4%). Items from the demographic and disease characteristics questionnaires were also included within our measurement model as predictors of self-advocacy. Because these questionnaires contain categorical items, we did not report total scale statistics here. See Table 2 for detailed information regarding descriptive statistics for these scales' items.
option to refuse participation and provide general, non-identifiable demographic information that we anticipated would be related to self-advocacy including age, time since diagnosis, race and education.
Each items had three to five categorical response options (e.g., age women who did participate in the study. Table 1 reports descriptive statistics for all measures. We tested the assumptions for a maximum likelihood factor analysis, subgroup analyses, and planned comparisons prior to data analyses. We used estimation maximization to address missing data (8.0%) in the FSACS Scale responses. We managed skewness and kurtosis concerns on the FSACS Scale related to ceiling effects by collapsing the first two response options into the third response option (e.g., 1 and 2 into 3) resulting in four rather than six response options.
We used data from our factor analysis of the FSACS's original 57 items to select a final, parsimonious set of items. We deleted 37 items based on their individual communalities, interitem correlations, item-to-total correlations, factor loadings, previous input from content validity experts and conceptual meaningfulness. We explored alternative extraction methods including 
| Hypothesis 1: Internal structure
We performed an Exploratory Factor Analysis using maximum likelihood method, oblique rotation because factors were assumed to be correlated, and scree plots to test if the internal structure of the and Factor 3 (5.6%, 1.1) contributed significantly as well. Table 3 shows the factor loadings for all three dimensions. We considered a factor loading of 0.4 indicative that an item was loading onto a specific factor, though our decisions were based on the totality of the item's performance. Three items on the "Communicating with My Healthcare Providers" subscale closely cross-loaded onto Factor 1, and one of these items also had low factor loadings. We considered multiple strategies to account for these overlapping score variances by evaluating the scale's performance with these items deleted, moved onto Factor 1, or retained on Factor 3. We also considered the performance of these three items during our previous face validity testing, cognitive interviews and pilot reliability study.
We decided to retain these three items onto Factor 3 because they were heavily endorsed as a part of communication during our previous content validity study (Hagan et al., 2016) , performed strongly during previous reliability testing, and since deleting these items did not impact the overall subscale or scale performance whereas deleting or moving these items reduced the subscales reliability and explanation of item variance.
The three factors had weak to moderately high inter-correlations.
"Being an Informed Decision Maker" correlated moderately with Reverse-scored item. *Indicates correlation is significant at a level below p = .001.
"Connected Strength" (r = .32, p < .01) and "Communicating with My
Healthcare Providers" (r = .56, p < .01). "Connected Strength" also correlated moderately with "Communicating with My Healthcare Providers" (r = .31, p < .01). Based on these associations, we decided to report on FSACS subscale scores to provide a more granular understanding of how each aspect of self-advocacy relates to other constructs though a total score is appropriate for general use of the scale.
| Hypothesis 2: Sensitivity to known groups
We tested the measure's sensitivity to detect differences between women anticipated to have varying levels of self-advocacy. We hypothesized that FSACS subscale scores would be significantly higher among (1) women with ≥5 years since diagnosis compared with women within 1 year of cancer diagnosis and (2) women with more than a bachelor's degree compared with women with a high school degree or less. We purposefully selected women on the extremes of both of these groups to detect differences between these groups. We used two-sided student t tests to test these comparisons with a level of significance set at a = 0.05 (used across all hypotheses). Table 4 compares FSACS subscale scores of these groups of participants. As hypothesized, women with higher levels of education scored significantly higher on all three FSACS subscales compared with women with lower levels of education. However, long-term survivors only had significantly higher scores than women within a year of cancer diagnosis on the "Being an Informed Decision Maker" subscale. 
| Hypothesis 5: Criterion measures
We tested criterion validity by comparing FSACS Scale scores and PSAS total scores on outcome measures. We expected that FSACS T A B L E 4 Hypothesis 2: FSACS scale sensitivity to differences between individuals with varying times since diagnosis and educational levels
Being an Informed Decision Maker Connected Strength
Communicating with My Healthcare Providers Scale scores should be more highly correlated with the outcome measures of symptom severity and interference and healthcare utilization than the PSAS total score. We calculated bivariate correlations between the PSAS scores and outcome variables and compared with the strength of association between the FSACS Scale and outcomes. The FSACS subscales were more highly correlated with the outcomes of symptom burden and healthcare utilization than the PSAS total score (Table 5 ). The PSAS scores were only related (positively) to hospitalizations in the past 3 months.
| DISCUSSION
Results of our five a priori hypotheses largely provided evidence for using the FSACS Scale as a measure of self-advocacy while also pointing to areas for future investigation. The internal structure of the FSACS Scale was consistent with the theoretical underpinnings of self-advocacy among female cancer survivors and provided a parsimonious set of 20 items tapping into three distinct dimensions of self-advocacy specific to a female oncology population. In this model, women's self-advocacy is defined as a woman (1) remains unclear whether self-advocacy is associated with a woman's ability to seek and obtain medical attention when such attention is prudent.
| Limitations
Limitations to this study are consistent with those of most survey studies. We were unable to verify self-reported disease and treatment information, and our response rate from the tumour registry was low; though we successfully recruited individuals from advocacy organizations. Since we were unable to compare our measure to a gold standard, we conducted tests of associations to evaluate the bivariate relationships of constructs within our measurement model;
based on these findings we will conduct more powerful model testing in the future that includes longitudinal assessment of predictors and outcomes of self-advocacy. In accordance with principles of instrument development, the sample in this study was purposefully broad to capture the full breadth of self-advocacy and be generalizable to all adult female cancer survivors. Future research explicitly will explore variations in self-advocacy among women who are likely to face greater challenges during their cancer experience including women with advanced cancers, recurrences, lower levels of education, financial problems, and from countries that do not share Western assumptions of autonomy, female gender and selfdetermination. Additionally, future research should focus on refining the communication subscale to clearly capture how cancer survivors get their needs met through communicating with their healthcare providers. We will continue to test and validate the FSACS Scale and measurement model with especially as we apply it to male cancer survivors and diverse cultures with different gender norms and healthcare systems (Brzyski, K ozka, Squires, & Brzostek, 2016; McGorry, 2000) .
| CONCLUSION
The FSACS Scale is a psychometrically sound measure of self-advocacy among female cancer survivors. In an environment in which patient-reported outcomes and patient-centred care require precise measurement, the FSACS Scale captures a critical construct like patient self-advocacy. As the first psychometric analysis of a measure of self-advocacy tailored to female cancer survivors, additional testing of the FSACS Scale will continue to refine the model and find targets for intervention. We will also use this measure to assess if a new intervention improves survivors' self-advocacy abilities and leads to improved symptom burden and healthcare utilization. This measure will assist clinicians and researchers in being able to support women ill-equipped to address their problems, needs and wants throughout their cancer experience.
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